Variable | Reinfused cases (n = 107) | Non-reinfused cases (n = 71) | p value |
---|---|---|---|
Age, y | 46.8 (19–79) | 46.4 (18–74) | 0.513 |
Sex | Â | Â | 0.841 |
 male | 89 | 58 |  |
 female | 18 | 13 |  |
Height, m | 1.55 (1.40–1.78) | 1.56 (1.40–1.75) | 0.178 |
Weight, kg | 55.3 (37–78) | 55.4 (37–70) | 0.839 |
BMI, kg/m2 | 23.1 (17.0–31.0) | 22.8 (15.4–28.7) | 0.641 |
ASA classification | Â | Â | 0.884 |
 I | 36 | 26 |  |
 II | 49 | 30 |  |
 III | 22 | 15 |  |
Tobacco use | 14 | 16 | 0.107 |
Crowe classification | Â | Â | 0.317 |
 III | 16 | 15 |  |
 IV | 91 | 56 |  |
HHS | 43.9 (26–61) | 41.3 (20–65) | 0.075 |
ROM, ° | 117.0 (15–225) | 122.9 (30–220) | 0.577 |
LLD, mm | 28.4 (0–60.0) | 17.1 (0–51.0) | < 0.001 a |
FO, mm | 36.1 (20.0–50.0) | 35.7 (21.0–48.0) | 0.527 |
COR height, mm | 60.3 (28.0-107.0) | 44.9 (14.0–81.0) | < 0.001 a |
Preoperative Hb, g/L | 132.9 (93.0-176.0) | 130.9 (85.0-164.0) | 0.586 |
Preoperative HCT, L/L | 0.40 (0.29–0.54) | 0.40 (0.27–0.48) | 0.636 |
Preoperative PLT, 10^9/L | 183.2 (86.0-437.0) | 189.7 (69.0-362.0) | 0.511 |
Preoperative APTT, seconds | 27.3 (16.0-35.3) | 28.3 (20.2–40.5) | 0.056 |
Preoperative PT, seconds | 11.2 (9.8–12.8) | 11.3 (9.4–13.6) | 0.374 |
Length of SSO, mm | 33.4 (1.0–60.0) | 24.2 (5.0–50.0) | < 0.001 a |
Intraoperative periprosthetic femoral fracture | 11 | 6 | 0.798 |
Drainage use | 35 | 26 | 0.630 |
Duration of operation, min | 139.2 (95–180) | 132.9 (97–190) | 0.171 |
Reinfused blood, ml | 246.1 (150–700) | - |  |
Allogeneic RBC transfused | 18 | 22 | 0.029 a |
Allogeneic RBC transfused, units | 2.7 (1.0–4.0) | 2.5 (1.5-4.0) | 0.368 |
Plasma transfused | 5 | 7 | 0.225 |
Plasma transfused, ml | 320.0 (200–600) | 314.3 (200–800) | 0.771 |